Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program

Atherosclerosis

Volumn 262, Issue , 2017, Pages 123-130

  Ikonomidis, Ignatios ^a   Marinou, Margarita ^a   Vlastos, Dimitrios ^a   Kourea, Kallirhoe ^a   Andreadou, Ioanna ^a   Liarakos, Nikolaos ^a   Triantafyllidi, Helen ^a   Pavlidis, George ^a   Tsougos, Elias ^a   Parissis, John ^a   Lekakis, John ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Arterial stiffness; Augmentation index; Glycocalyx; Nicotine replacement therapy; Nitric oxide; Pulse wave velocity; Smoking cessation; Varenicline

Indexed keywords

CARBON MONOXIDE; CARBONYL DERIVATIVE; MALONALDEHYDE; VARENICLINE; NICOTINE GUM; NICOTINIC AGENT;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; GLYCOCALYX; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NICOTINE REPLACEMENT THERAPY; OXIDATIVE STRESS; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; SMOKING; SMOKING CESSATION PROGRAM; VISCOELASTICITY; BREATH ANALYSIS; COMPARATIVE STUDY; DRUG EFFECTS; ENDOTHELIUM CELL; GREECE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROTEIN CARBONYLATION; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TIME FACTOR; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

ADULT; AGED; BREATH TESTS; CARBON MONOXIDE; ENDOTHELIAL CELLS; FEMALE; GLYCOCALYX; GREECE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; NICOTINIC AGONISTS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PULSE WAVE ANALYSIS; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TREATMENT OUTCOME; VARENICLINE; VASCULAR STIFFNESS;

EID: 85019927913     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2017.05.012     Document Type: Article

References (34)

1. Teo, K.K., Ounpuu, S., Hawken, S., Pandey, M.R., Valentin, V., Hunt, D., Diaz, R., Rashed, W., Freeman, R., Jiang, L., Zhang, X., Yusuf, S., Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368 (2006), 647–658.
2. Li, H., Srinivasan, R.S., Berenson, G.S., Comparison of measures of pulsatile arterial function between asymptomatic younger adult smokers and former smokers: the Bogalusa Heart Study. Am. J. Hypertens. 19 (2006), 897–901.
3. Messner, Barbara, Bernhard, David, Smoking and cardiovascular disease mechanisms of endothelial dysfunction and early atherogenesis. Arteriosclerosis, Thrombosis, Vasc. Biol. 34 (2014), 509–515.
4. Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., Pannier, B., Vlachopoulos, C., Wilkinson, I., Struijker-Boudier, H., Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 27 (2006), 2588–3260.
5. Boutouyrie, P., Tropeano, A.I., Asmar, R., Gautier, I., Benetos, A., Lacolley, P., Laurent, S., Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 39 (2002), 10–15.
6. Reitsma, S., Slaaf, D.W., Vink, H., van Zandvoort, M.A., oude Egbrink, M.G., The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 454 (2007), 345–359.
7. Van Teeffelen, J.W., Brands, J., Stroes, E.S., Vink, H., Endothelial glycocalyx: sweet shield of blood vessels. Trends Cardiovasc Med. 17 (2007), 101–105.
8. Nieuwdorp, M., van Haeften, T.W., Gouverneur, M.C., Mooij, H.L., van Lieshout, M.H., Levi, M., Meijers, J.C., Holleman, F., Hoekstra, J.B., Vink, H., Kastelein, J.J., Stroes, E.S., Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55 (2006), 480–486.
9. Vlahu, C.A., Lemkes, B.A., Struijk, D.G., Koopman, M.G., Krediet, R.T., Vink, H., Damage of the endothelial glycocalyx in dialysis patients. J. Am. Soc. Nephrol. 23 (2012), 1900–1908, 10.1681/ASN2011121181.
10. Marechal, X., Favory, R., Joulin, O., Montaigne, D., Hassoun, S., Decoster, B., Zerimech, F., Neviere, R., Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 29 (2008), 572–576, 10.1097/SHK.0b013e318157e926.
11. Nieuwdorp, M., Meuwese, M.C., Mooij, H.L., Ince, C., Broekhuizen, L.N., Kastelein, J.J., Stroes, E.S., Vink, H., Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. J. Appl. Physiol. 104 (2008), 845–852.
12. Ikonomidis, I., Pavlidis, G., Lambadiari, V., Kousathana, F., Varoudi, M., Spanoudi, F., Maratou, E., Parissis, J., Triantafyllidi, H., Dimitriadis, G., Lekakis, J., Early detection of left ventricular dysfunction in first-degree relatives of diabetic patients by myocardial deformation imaging: the role of endothelial glycocalyx damage. Int. J. Cardiol., 2017, 10.1016/j.ijcard.2017.01.056 10 Available online 8 January 2017.
13. Lekakis, J., Abraham, P., Balbarini, A., Blann, A., Boulanger, C.M., Cockcroft, J., Cosentino, F., Deanfield, J., Gallino, A., Ikonomidis, I., Kremastinos, D., Landmesser, U., Protogerou, A., Stefanadis, C., Tousoulis, D., Vassalli, G., Vink, H., Werner, N., Wilkinson, I., Vlachopoulos, C., Methods for evaluating endothelial function: a position statement from the European society of Cardiology working group on peripheral circulation. Eur. J. Cardiovasc Prev. Rehabil. 18 (2011), 775–789.
14. Ikonomidis, I., Tzortzis, S., Andreadou, I., Paraskevaidis, I., Katseli, C., Katsimbri, P., Pavlidis, G., Parissis, J., Kremastinos, D., Anastasiou-Nana, M., Lekakis, J., Increased benefit of interleukin-1 inhibition on vascular function, myocardial deformation, and twisting in patients with coronary artery disease and coexisting rheumatoid arthritis. Circ. Cardiovasc Imaging 7 (2014), 619–628, 10.1161/CIRCIMAGING.113.001193.
15. Dalle-Donne, I., Rossi, R., Giustarini, D., Milzani, A., Colombo, R., Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 329:1–2 (2003), 23–38.
16. Pipe, A.L., Eisenberg, M.J., Gupta, A., Reid, R.D., Suskin, N.G., Stone, J.A., Smoking cessation and the cardiovascular specialist: canadian Cardiovascular Society position paper. Can. J. Cardiol. 27 (2011), 132–137.
17. Leon, Arthur S., AHA Scientific Statement. Cardiac rehabilitation and secondary prevention of coronary heart disease. An american heart association scientific statement from the council on clinical Cardiology (subcommittee on exercise, cardiac rehabilitation, and prevention) and the council on nutrition, physical activity, and metabolism (subcommittee on physical activity), in collaboration with the american association of cardiovascular and pulmonary rehabilitation. Circulation 124 (2011), 2458–2473.
18. Benowitz, N.L., Gourlay, S.G., Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J. Am. Coll. Cardiol. 29 (1997), 1422–1431.
19. Ware JH, Vetrovec GW, Miller AB, Van Tosh A, Gaffney M, Yunis C, Arteaga C, Borer JS. Cardiovascular safety of varenicline: patient-level meta-analysis of randomized, blinded, placebo-controlled trials. Am. J. Ther. 201;20:235–246. doi: 10.1097/MJT.0b013e31828d455b.
20. Ikonomidis, I., Tzortzis, S., Papaioannou, T., Protogerou, A., Stamatelopoulos, K., Papamichael, C., Zakopoulos, N., Lekakis, J., Incremental value of arterial wave reflections in the determination of left ventricular diastolic dysfunction in untreated patients with essential hypertension. J. Hum. Hypertens. 22 (2008), 687–698.
21. Parissis, J.T., Kourea, K., Andreadou, I., Ikonomidis, I., Markantonis, S., Ioannidis, K., Paraskevaidis, I., Iliodromitis, E., Filippatos, G., Kremastinos DT.Effects of Darbepoetin Alfa on plasma mediators of oxidative and nitrosative stress in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 103 (2009), 1134–1138.
22. Berlin, I., Cournot, A., Renout, P., Duchier, J., Safar, M., Peripheral haemodynamic effects of smoking in habitual smokers. A methodological study. Eur. J. Clin. Pharmacol. 38 (1990), 57–60.
23. Rehill, N., Beck, C.R., Yeo, K.R., Yeo, W.W., The effect of chronic tobacco smoking on arterial stiffness. Br. J. Clin. Pharmacol. 61 (2006), 767–773.
24. Argacha, J.F., Adamopoulos, D., Gujic, M., Fontaine, D., Amyai, N., Berkenboom, G., Van de, B.P., Acute effects of passive smoking on peripheral vascular function. Hypertension 51 (2008), 1506–1511.
25. Lee, R.T., Kamm, R.D., Vascular mechanics for the cardiologist. J. Am. Coll. Cardiol., 1994, 1289–1295.
26. Celermajer, D.S., Sorensen, K.E., Gooch, V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992), 1111–1115.
27. Ikonomidis, I., Lekakis, J., Vamvakou, G., Andreotti, F., Nihoyannopoulos, P., Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. Am. Heart J. 149 (2005), 832–839 PubMed PMID: 15894964.
28. Johnson, Heather M., Effects of smoking and smoking cessation on endothelial function: one-year outcomes from a randomized clinical trial. J. Am. Coll. Cardiol. 55 (2010), 1988–1995.
29. Webster, W.S., Clarkson, T.B., Lofland, H.B., Carbon monoxide-aggravated atherosclerosis in the squirrel monkey. Exp. Mol. Pathol. 13 (1970), 36–50.
30. Settasatian, N., Settasatian, C., Yongsakulchai, P., Sarutipaiboon, I., Pitivejthurakit, P., et al. Breath carbon monoxide and carboxyhemoglobin are related to abnormal blood lipid profile in smokers. Atherosclerosis 235 (2014), e283–e284.
31. Peluffo, G., Calcerrada, P., Piacenza, L., Pizzano, N., Radi, R., Superoxide-mediated inactivation of nitric oxide and peroxynitrite formation by tobacco smoke in vascular endothelium: studies in cultured cells and smokers. Am. J. Physiol. Heart Circ. Physiol. 296 (2009), H1781–H1792.
32. Weber, D., Davies, M.J., Grune, T., Determination of protein carbonyls in plasma, cell extracts, tissue homogenates, isolated proteins: focus on sample preparation and derivatization conditions. Redox Biol. 5 (2015), 367–380, 10.1016/j.redox.2015.06.005.
33. Delles, C., Zimmerli, L.U., McGrane, D.J., Koh-Tan, C.H., Pathi, V.L., McKay, A.J., Steedman, T., Dargie, H.J., Hamilton, C.A., Dominiczak, A.F., Vascular stiffness is related to superoxide generation in the vessel wall. J. Hypertens. 26 (2008), 946–955.
34. Mandraffino, G., Aragona, C.O., Scuruchi, M., Mamone, F., D'Ascola, A., et al. Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. Atherosclerosis, 2017 Published online: January 14 http://dx.doi.org/10.1016/j.atherosclerosis.2017.01.012.